Electrodes & Welding Equipment · Founded 1987 · www.esabindia.com · BSE 500133 · NSE ESAB INDIA · ISIN INE284A01012
No Notes Added Yet
Business
Esab India Ltd. is a leading manufacturer and supplier of welding and cutting equipment and consumables. The company primarily operates in the industrial sector, providing a comprehensive range of products including manual welding electrodes, welding wires, welding and cutting machines, automation solutions for welding, and plasma cutting systems. Its core business model involves manufacturing these products in India and distributing them through an extensive network to various industries such as automotive, heavy engineering, infrastructure, power, shipbuilding, and general fabrication. The company makes money by selling these high-quality, often technologically advanced, products and related services to its industrial customer base.
Revenue Mix
While specific revenue breakdowns are not provided in the prompt, Esab India's operations typically fall into two major segments:
Welding Consumables: This segment includes a wide range of electrodes, filler metals, and wires used in various welding processes.
Welding & Cutting Equipment: This segment comprises manual welding machines, robotic welding systems, plasma cutting equipment, and other automation solutions.
The company's revenue mix generally leans towards consumables due to their repetitive purchase nature, while equipment sales provide larger, often project-based, revenue streams.
Industry
The Indian electrodes and welding equipment industry is characterized by a mix of organized and unorganized players, as well as domestic and international competition. It is cyclical, tied closely to industrial growth, infrastructure development, and capital expenditure. Esab India, being part of the global ESAB group (owned by Enovis Corporation, USA), holds a strong leadership position in the organized sector. It is recognized for its advanced technology, product quality, and wide product portfolio. It competes with other multinational brands like Lincoln Electric and Kemppi, as well as prominent domestic players. Its global backing provides a significant advantage in terms of R&D and product innovation.
MOAT
Esab India possesses several durable competitive advantages:
Brand & Technology: Leveraging the global ESAB brand, it benefits from a reputation for high-quality, reliable, and technologically advanced products, backed by global R&D.
Extensive Product Portfolio: Offers a comprehensive range of welding and cutting solutions, catering to diverse industrial needs, which allows for cross-selling and reduces reliance on single product lines.
Distribution & Service Network: Likely has a well-established and widespread sales, distribution, and service network across India, crucial for reaching industrial customers and providing post-sales support.
Customer Stickiness: For critical industrial applications, customers often prefer proven brands and high-performance products, leading to repeat business and long-term relationships.
Growth Drivers
Infrastructure Development: Government's continued focus and investment in infrastructure projects (roads, railways, power, ports) will drive demand for welding and cutting solutions.
"Make in India" & Manufacturing Growth: Initiatives promoting domestic manufacturing across sectors like automotive, heavy engineering, shipbuilding, and defense will fuel industrial demand.
Automation Adoption: Increasing emphasis on productivity, quality, and safety is driving the adoption of advanced welding automation and robotic solutions.
Replacement & Upgrade Cycle: Existing industrial units will require replacement and upgrade of older equipment and consumables to improve efficiency and comply with modern standards.
Export Potential: Opportunities to leverage India's manufacturing base for exporting welding products to neighboring regions.
Risks
Economic Downturn: The company's performance is highly cyclical and dependent on industrial capital expenditure. A slowdown in the overall economy or manufacturing sector can significantly impact demand.
Raw Material Price Volatility: Fluctuations in prices of key raw materials such as steel, copper, and various chemicals can impact manufacturing costs and profitability.
Intense Competition: The market faces competition from both organized and unorganized players, including lower-cost imported products, which can exert pressure on pricing and market share.
Technological Obsolescence: Rapid advancements in welding technology require continuous investment in R&D and product upgrades to remain competitive.
Currency Fluctuations: Exposure to currency risks due to import of certain components or technologies.
Management & Ownership
Esab India Ltd. is a subsidiary of Enovis Corporation, a globally diversified medical technology and industrial company based in the USA. The global parent holds a significant majority stake, acting as the promoter. This structure generally ensures professional management practices, adherence to global governance standards, and strategic direction from the parent company, often bringing global best practices and technological know-how. The management team is expected to be professionally run, aligning with the global corporate standards of Enovis.
Outlook
Esab India is well-positioned to capitalize on India's projected industrial growth and infrastructure boom. Its strong brand, comprehensive product portfolio, technological edge, and extensive distribution network provide a solid foundation for growth, particularly with the increasing adoption of automation and advanced welding processes. The "Make in India" initiative and robust CAPEX plans in various industrial sectors are strong tailwinds. However, the company is susceptible to cyclical downturns in the industrial economy and volatility in raw material prices. Intense competition, including from lower-cost alternatives, will continue to put pressure on market share and margins. Sustained investment in R&D and an agile strategy to adapt to evolving market demands will be crucial for maintaining its leadership position and ensuring long-term profitability amidst these challenges.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 341 | 330 | 339 | 337 | 368 | 352 | 382 | 379 | 396 | 421 |
| Other Income | 1 | 1 | 1 | 3 | 2 | 1 | 2 | 1 | 2 | 2 |
| Total Income | 342 | 331 | 340 | 341 | 370 | 353 | 384 | 380 | 397 | 423 |
| Total Expenditure | 277 | 268 | 277 | 282 | 302 | 293 | 309 | 303 | 333 | 342 |
| Operating Profit | 65 | 63 | 63 | 59 | 68 | 60 | 75 | 77 | 65 | 81 |
| Interest | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 |
| Depreciation | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 31 | -14 | 0 | 0 |
| Profit Before Tax | 60 | 60 | 59 | 55 | 63 | 55 | 101 | 58 | 60 | 76 |
| Provision for Tax | 16 | 15 | 16 | 14 | 15 | 14 | 22 | 15 | 16 | 20 |
| Profit After Tax | 44 | 44 | 43 | 40 | 47 | 41 | 79 | 43 | 44 | 56 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 44 | 44 | 43 | 40 | 47 | 41 | 79 | 43 | 44 | 56 |
| Adjusted Earnings Per Share | 28.8 | 28.9 | 28 | 26.2 | 30.8 | 26.6 | 51.5 | 27.9 | 28.3 | 36.5 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 451 | 466 | 532 | 672 | 698 | 689 | 908 | 1104 | 1259 | 1390 | 1525 | 1578 |
| Other Income | 8 | 13 | 13 | 17 | 14 | 11 | 5 | 8 | 6 | 8 | 6 | 7 |
| Total Income | 459 | 480 | 545 | 688 | 711 | 700 | 913 | 1112 | 1266 | 1398 | 1531 | 1584 |
| Total Expenditure | 404 | 422 | 480 | 593 | 601 | 606 | 787 | 918 | 1030 | 1145 | 1255 | 1287 |
| Operating Profit | 54 | 57 | 65 | 96 | 111 | 94 | 126 | 195 | 236 | 253 | 276 | 298 |
| Interest | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 2 | 2 | 3 | 1 |
| Depreciation | 10 | 10 | 10 | 11 | 13 | 12 | 11 | 12 | 14 | 15 | 17 | 17 |
| Exceptional Income / Expenses | -4 | -9 | -2 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 17 | 17 |
| Profit Before Tax | 41 | 38 | 53 | 84 | 97 | 81 | 114 | 182 | 220 | 236 | 274 | 295 |
| Provision for Tax | 13 | 11 | 15 | 27 | 26 | 21 | 29 | 47 | 57 | 60 | 67 | 73 |
| Profit After Tax | 28 | 27 | 37 | 58 | 71 | 59 | 84 | 136 | 163 | 175 | 207 | 222 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 28 | 27 | 37 | 58 | 71 | 59 | 84 | 136 | 163 | 175 | 207 | 222 |
| Adjusted Earnings Per Share | 18.4 | 17.5 | 24.1 | 37.4 | 46.4 | 38.5 | 54.8 | 88.2 | 105.9 | 114 | 134.3 | 144.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 10% | 11% | 17% | 13% |
| Operating Profit CAGR | 9% | 12% | 24% | 18% |
| PAT CAGR | 18% | 15% | 29% | 22% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 11% | 4% | 20% | 25% |
| ROE Average | 52% | 54% | 50% | 31% |
| ROCE Average | 70% | 73% | 68% | 42% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 316 | 343 | 378 | 267 | 338 | 259 | 244 | 260 | 306 | 361 | 429 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2 | 1 | 1 | 2 | 6 | 5 | 5 | 9 | 9 | -0 | 15 |
| Total Current Liabilities | 66 | 83 | 99 | 109 | 113 | 122 | 185 | 204 | 234 | 276 | 245 |
| Total Liabilities | 384 | 426 | 479 | 377 | 457 | 387 | 434 | 473 | 549 | 638 | 690 |
| Fixed Assets | 78 | 76 | 80 | 83 | 86 | 90 | 90 | 95 | 125 | 136 | 148 |
| Other Non-Current Assets | 37 | 36 | 12 | 12 | 11 | 6 | 9 | 27 | 15 | 23 | 16 |
| Total Current Assets | 269 | 313 | 385 | 281 | 357 | 289 | 334 | 349 | 407 | 477 | 525 |
| Total Assets | 384 | 426 | 479 | 377 | 457 | 387 | 434 | 473 | 549 | 638 | 690 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 20 | 27 | 39 | 37 | 43 | 19 | 19 | 21 | 33 | 38 | 65 |
| Cash Flow from Operating Activities | 18 | 37 | 30 | 67 | 57 | 72 | 85 | 129 | 141 | 199 | 181 |
| Cash Flow from Investing Activities | -9 | -23 | 9 | 102 | -120 | 66 | 20 | 5 | -55 | -15 | -46 |
| Cash Flow from Financing Activities | -2 | -2 | -41 | -163 | 39 | -139 | -102 | -122 | -81 | -157 | -143 |
| Net Cash Inflow / Outflow | 7 | 12 | -2 | 6 | -24 | -0 | 3 | 12 | 5 | 27 | -8 |
| Closing Cash & Cash Equivalent | 27 | 39 | 37 | 43 | 19 | 19 | 21 | 33 | 38 | 65 | 57 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 18.41 | 17.45 | 24.14 | 37.42 | 46.4 | 38.53 | 54.78 | 88.16 | 105.9 | 113.98 | 134.3 |
| CEPS(Rs) | 24.6 | 24.13 | 30.7 | 44.37 | 54.57 | 46.13 | 62.14 | 95.88 | 114.86 | 123.68 | 145.39 |
| DPS(Rs) | 1 | 1 | 1 | 90 | 70 | 44 | 60 | 78 | 86 | 90 | 75 |
| Book NAV/Share(Rs) | 205.03 | 222.58 | 245.78 | 173.22 | 219.46 | 168.43 | 158.69 | 169.12 | 198.87 | 234.73 | 279 |
| Core EBITDA Margin(%) | 9.39 | 8.64 | 9.51 | 11.74 | 13.87 | 11.95 | 13.24 | 16.85 | 18.1 | 17.41 | 17.51 |
| EBIT Margin(%) | 8.37 | 7.46 | 9.68 | 12.53 | 14 | 11.88 | 12.51 | 16.48 | 17.52 | 16.9 | 17.91 |
| Pre Tax Margin(%) | 8.3 | 7.38 | 9.64 | 12.49 | 13.88 | 11.62 | 12.45 | 16.44 | 17.35 | 16.76 | 17.75 |
| PAT Margin (%) | 5.73 | 5.27 | 6.81 | 8.55 | 10.19 | 8.56 | 9.24 | 12.23 | 12.85 | 12.47 | 13.39 |
| Cash Profit Margin (%) | 7.65 | 7.28 | 8.65 | 10.14 | 11.99 | 10.25 | 10.48 | 13.3 | 13.94 | 13.53 | 14.49 |
| ROA(%) | 7.54 | 6.63 | 8.21 | 13.45 | 17.12 | 14.06 | 20.53 | 29.9 | 31.9 | 29.57 | 31.15 |
| ROE(%) | 9.37 | 8.16 | 10.31 | 17.86 | 23.63 | 19.86 | 33.49 | 53.79 | 57.56 | 52.58 | 52.28 |
| ROCE(%) | 13.71 | 11.56 | 14.67 | 26.18 | 32.46 | 27.57 | 45.36 | 72.47 | 78.45 | 71.26 | 69.97 |
| Receivable days | 32.87 | 33.01 | 35.37 | 33.21 | 38.61 | 48.31 | 46.82 | 47.31 | 49.1 | 53.86 | 56.77 |
| Inventory Days | 41.45 | 43.4 | 45.32 | 38.16 | 38.18 | 40.01 | 35.68 | 37.57 | 33.78 | 31.39 | 32.07 |
| Payable days | 63.7 | 62.08 | 69.89 | 67.25 | 72.25 | 76.68 | 77.68 | 80.29 | 69.97 | 73.45 | 83.42 |
| PER(x) | 34.23 | 34.69 | 29.22 | 24.42 | 23.16 | 46.58 | 55.34 | 40.11 | 49.64 | 39.9 | 36.9 |
| Price/Book(x) | 3.07 | 2.72 | 2.87 | 5.27 | 4.9 | 10.65 | 19.1 | 20.91 | 26.44 | 19.37 | 17.76 |
| Dividend Yield(%) | 0.16 | 0.17 | 0.14 | 9.85 | 6.51 | 2.45 | 1.98 | 2.21 | 1.64 | 1.98 | 1.51 |
| EV/Net Sales(x) | 2.07 | 1.91 | 1.92 | 2.01 | 2.23 | 3.95 | 5.09 | 4.88 | 6.35 | 4.98 | 4.95 |
| EV/Core EBITDA(x) | 17.16 | 15.51 | 15.76 | 14.09 | 14.04 | 28.94 | 36.82 | 27.67 | 33.92 | 27.39 | 27.32 |
| Net Sales Growth(%) | -18.28 | 3.42 | 14.02 | 26.29 | 3.92 | -1.27 | 31.74 | 21.65 | 14.04 | 10.35 | 9.75 |
| EBIT Growth(%) | 33.2 | -8.23 | 39 | 59.7 | 16.19 | -16.12 | 38.76 | 60.1 | 21.53 | 7.02 | 16.34 |
| PAT Growth(%) | 19.88 | -5.22 | 38.31 | 55.02 | 24 | -16.97 | 42.2 | 60.93 | 20.12 | 7.63 | 17.83 |
| EPS Growth(%) | 19.88 | -5.22 | 38.31 | 55.02 | 24 | -16.97 | 42.2 | 60.93 | 20.12 | 7.63 | 17.83 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 4.08 | 3.78 | 3.88 | 2.59 | 3.15 | 2.37 | 1.8 | 1.71 | 1.74 | 1.72 | 2.14 |
| Quick Ratio(x) | 3.19 | 3.02 | 3.15 | 1.96 | 2.46 | 1.77 | 1.24 | 1.11 | 1.26 | 1.25 | 1.57 |
| Interest Cover(x) | 121.88 | 105.64 | 240.27 | 301.5 | 115.4 | 47.02 | 187.16 | 365.58 | 101.44 | 117.12 | 106.79 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 |
| FII | 1.27 | 1.53 | 1.66 | 1.85 | 1.79 | 1.56 | 1.53 | 1.51 | 1.55 | 1.62 |
| DII | 13.03 | 13.04 | 13.04 | 12.95 | 12.72 | 12.67 | 12.62 | 12.78 | 12.73 | 12.71 |
| Public | 11.98 | 11.7 | 11.58 | 11.48 | 11.77 | 12.05 | 12.13 | 11.99 | 11.99 | 11.94 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
| FII | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| DII | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.19 | 0.2 | 0.2 | 0.2 |
| Public | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.19 | 0.19 | 0.18 | 0.18 | 0.18 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +10% | +11% | +17% | +13% |
| Operating Profit CAGR | +9% | +12% | +24% | +18% |
| PAT CAGR | +18% | +15% | +29% | +22% |
| Share Price CAGR | +11% | +4% | +20% | +25% |
| ROE Average | +52% | +54% | +50% | +31% |
| ROCE Average | +70% | +73% | +68% | +42% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 | 73.72 |
| FII | 1.27 | 1.53 | 1.66 | 1.85 | 1.79 | 1.56 | 1.53 | 1.51 | 1.55 | 1.62 |
| DII | 13.03 | 13.04 | 13.04 | 12.95 | 12.72 | 12.67 | 12.62 | 12.78 | 12.73 | 12.71 |
| Public | 11.98 | 11.7 | 11.58 | 11.48 | 11.77 | 12.05 | 12.13 | 11.99 | 11.99 | 11.94 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 | 1.13 |
| FII | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| DII | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.19 | 0.2 | 0.2 | 0.2 |
| Public | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.19 | 0.19 | 0.18 | 0.18 | 0.18 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.